NASDAQ:BCAX | Free Cash Flow | Bicara Therapeutics Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2023-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$37.51M$60,000.00-$37.57M
2025-12-31-$23.89M$238,000.00-$24.12M
2025-03-31-$28.11M$0.00-$28.11M
2024-12-31-$30.03M$40,000.00-$30.07M
2024-03-31-$14.59M$4,000.00-$14.59M
2023-12-31-$8.04M$436,000.00-$8.47M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$106.83M$280,000.00-$107.11M
2024-12-31-$74.75M$71,000.00-$74.82M
2023-12-31-$45.63M$586,000.00-$46.21M